R&D investment continues to climb, especially in the clinical development space, with major pharmaceutical players such as Merck, Roche, and Johnson & Johnson leading 2024’s global R&D spending. However, this growth occurs against a backdrop of growing global uncertainty. Shifting tariff policies, unpredictable trade agreements, and broader geopolitical instability are creating new pressures on procurement teams to protect budgets and remain resilient in light of current supply chain instability. It has never been more important for R&D procurement and sourcing professionals across biopharma to unite and understand how to futureproof against such pressures and adjust their sourcing strategies, whilst ultimately achieving corporate milestones.

The 9th R&D Procurement & Sourcing in Pharma Summit returns with reimagined strategic and implementation procurement tracks dedicated to you and the team to transform wider and day-to-day operations. Uniting 100+ biopharma procurement professionals, we will be uncovering AI-driven efficiency, insights to help develop teams from the ground up, and tips to remain agile in light of an externally changing market.

Event link here.